激酶活化型急性髓系白血病中质子分配调控及其治疗意义
该研究报道激酶突变通过激活钠/氢交换体1(NHE1)诱导细胞内碱化以支持急性髓系白血病(AML)细胞存活,阿米洛利可增强激酶抑制剂和化疗的抗白血病效应,提示靶向NHE1介导的细胞内碱化具有治疗潜力。
要点
- 激酶突变通过磷酸化NHE1维持细胞内碱性pH并支持AML细胞存活。
- 阿米洛利增强激酶抑制剂和化疗的抗白血病效应及细胞内分布。
- NHE1与激酶协同抑制在体内外协同酸化白血病细胞并抑制生长。
核心结论
- NHE1介导的细胞内碱化在传递突变激酶增殖信号中起关键致病作用,可被利用于AML的治疗干预。
研究设计与样本
- 研究在正常造血祖细胞中检测13种激酶对钠/氢交换体(NHE1)的激活,并分析FLT3-ITD、KRASG12D和BTK对NHE1的磷酸化作用及对AML细胞存活的影响,同时检测原代AML样本中NHE1磷酸化及依赖性证据。
主要发现
- 13种激酶在正常造血祖细胞中可激活NHE1,其中FLT3-ITD、KRASG12D和BTK磷酸化NHE1以维持细胞内碱性pH并支持AML细胞存活。
- 携带激酶突变的原代AML样本显示NHE1磷酸化增加及NHE1依赖性证据。
- 阿米洛利增强激酶抑制剂和化疗的抗白血病效应及细胞内分布。
- NHE1与激酶协同抑制在白血病中协同酸化细胞内pH并在体内抑制其生长。
- 服用阿米洛利利尿的患者血浆在体外降低白血病细胞pH并增强激酶抑制剂和化疗的细胞毒效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gain-of-function kinase mutations are common in AML and usually portend an inferior prognosis. We reported a novel mechanism whereby kinase mutants induced intracellular alkalization characteristic in oncogenesis. Thirteen kinases were found to activate sodium/hydrogen exchanger (NHE1) in normal hematopoietic progenitors, of which FLT3-ITD, KRASG12D, and BTK phosphorylated NHE1 maintained alkaline intracellular pH (pHi) and supported survival of AML cells. Primary AML samples with kinase mutations also showed increased NHE1 phosphorylation and evidence of NHE1 addiction. Amiloride enhanced anti-leukemic effects and intracellular distribution of kinase inhibitors and chemotherapy. Co-inhibition of NHE1 and kinase synergistically acidified pHi in leukemia and inhibited its growth in vivo. Plasma from patients taking amiloride for diuresis reduced pHi of leukemia and enhanced cytotoxic effects of kinase inhibitors and chemotherapy in vitro. NHE1-mediated intracellular alkalization played a key pathogenetic role in transmitting the proliferative signal from mutated-kinase and could be exploited for therapeutic intervention in AML.
引用
- Man CH, Zeng X, Lam W, et al. Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication. Leukemia. 2022. PMID: 35624145. doi:10.1038/s41375-022-01606-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。